SARS-CoV-2 Envelope (SARS-CoV-2 E) (N-Term) Peptide
Our Local Distributor
北京 101111
Quick Overview for SARS-CoV-2 Envelope (SARS-CoV-2 E) (N-Term) Peptide (ABIN1382276)
抗原
宿主
应用范围
-
-
蛋白结构域
- N-Term
-
产品特性
-
10 amino acids near the amino terminus of SARS E protein.
Virus
-
-
-
应用备注
- SARS envelope peptide is used for blocking the activity of the SARS envelope.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 200 μg/mL
-
缓冲液
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
有效期
- 12 months
-
-
- SARS-CoV-2 Envelope (SARS-CoV-2 E)
-
物质类
- Viral Protein
-
背景
- Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak. The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.
抗原
-